Clinical Trial Update: A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of fesoterodine for symptoms of overactive bladder, including nocturnal urinary urgency; study completed with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Fesoterodine (fesoterodine)

Snippet

Sponsor: Pfizer | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2012-08-14